e-learning
resources
Vienna 2009
Monday, 14.09.2009
Clinical aspects and epidemiology in lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Earlier stages, higher incidence of squamous and lower incidence of small cell and adenocarcinomas among lung cancer patients with coexisting COPD
E. Podmaniczky, D. Bartusek, I. S. Sári, J. Moldvay, G. Losonczy, P. Barta (Budapest, Hungary)
Source:
Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer
Session:
Clinical aspects and epidemiology in lung cancer
Session type:
Thematic Poster Session
Number:
2692
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Podmaniczky, D. Bartusek, I. S. Sári, J. Moldvay, G. Losonczy, P. Barta (Budapest, Hungary). Earlier stages, higher incidence of squamous and lower incidence of small cell and adenocarcinomas among lung cancer patients with coexisting COPD. Eur Respir J 2009; 34: Suppl. 53, 2692
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
COPD is a risk factor for squamous cell histotype in smokers who develop nonsmall cell lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 361s
Year: 2003
COPD as an independent risk factor for lung cancer in patients with bronchial squamous dysplasia
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011
Predictors of major serious manifestations in the terminal stage of lung cancer
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005
Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis
Source: Eur Respir J 2008; 31: 854-859
Year: 2008
Late lung metastasis of endometrial cancer. Two rare cases of patients with late lung metastasis of primary endometrial cancer 14 and 17 years after initial treatment
Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology
Year: 2012
The risk of distant metastases and prognosis prediction in early stage squamous cell lung cancer (SqCLC) by means of 3 microRNAs expression assessment
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011
Incidence of lung cancer among COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 494s
Year: 2005
Multiple carcinomas in the lung cancer patients
Source: Eur Respir J 2007; 30: Suppl. 51, 671s
Year: 2007
Interleukine-17A implicated in survival outcome of patients with late stage lung adenocarcinoma
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018
Pancreatic polypeptide is increased in patients with advanced malignant disease including lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 232s
Year: 2002
Bronchial bacterial colonization in patients with resectable lung carcinoma
Source: Eur Respir J 2002; 19: 326-332
Year: 2002
Non-small cell lung cancer resected molecular expression in COPD and low function pulmonary patients
Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies
Year: 2007
COPD and lung cancer incidence in never smokers
Source: International Congress 2019 – Asthma and COPD comorbidities
Year: 2019
Coexistence of COPD in lung cancer patients
Source: Eur Respir J 2001; 18: Suppl. 33, 66s
Year: 2001
Small cell lung cancer in patients with elderly
Source: Annual Congress 2007 - Therapy of lung cancer
Year: 2007
Predictors of radiation-induced lung toxicity in patients with locally advanced non small cell lung cancer (NSCLC): a retrospective analysis
Source: Annual Congress 2009 - Management of thoracic malignancies
Year: 2009
Real-world treatment patterns and outcomes of patients with extensive disease small cell lung cancer (ED SCLC)
Source: International Congress 2019 – Treatment of lung cancer
Year: 2019
Coexistence of chronic obstructive pulmonary disease in patients with advanced non-small cell lung cancer and impact on survival
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017
The prevalence of undiagnosed COPD and approaches to promote early COPD diagnosis in lung cancer population
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept